All Stories

  1. Therapeutic potential of nitrogen-containing heterocyclic compounds in Alzheimer's disease: From molecular design to SAR studies
  2. The molecular landscape of kidney stone disease: pathophysiology to personalized intervention
  3. Computationally guided synthesis and biological profiling of chalcones as antioxidant and anti-inflammatory activities
  4. Exosome as emerging therapeutic platform for wound healing: Current status, advancement and future crosstalk
  5. Oleosomes as emerging Next-Generation carrier for topical drug delivery
  6. Enzymatic and Nonenzymatic Mechanisms of ROS Generation in Metabolic Disorders
  7. The melatonin-microbiome axis: a new frontier in gut health for the immunomodulatory, antioxidant and anti-inflammatory properties
  8. Assessment of Polyherbal Formulation for Hepatoprotective Activity in Carbon Tetrachloride-Induced Liver Toxicity
  9. Microbiota-brain interaction: The role of gut-derived proteins in addressing various neurological disorders including Parkinson’s (PD) and Alzheimer’s diseases (AD)
  10. A comprehensive review of the bioactive compounds and the various pharmacological activities of Mahua (Madhuca longifolia) plant
  11. Role of Mediterranean Diet in Alzheimer’s Disease: Pre-clinical and Clinical Evidence
  12. Evaluation of Suitability, Efficacy, and Safety of Zinc Hydroxide Adjuvant System Adsorbed on Tetanus Toxoid Vaccine
  13. Design and development of N-Heterocyclic protease inhibitors for flaviviral infections: a synthetic and SAR-based review
  14. Revolutionizing vaccination: the marvel of nanovaccination technology
  15. Targeting tryparedoxin-dependent peroxidase (TXNPx) enzyme to identify repurposing drug candidates from FDA-approved drugs and natural products using virtual screening, ADME/Tox and MD simulations
  16. Application of Machine Learning (ML) approach in discovery of novel drug targets against Leishmania: A computational based approach
  17. Development and Assessment of Electrospun Nanofibrous Wound Dressing Containing Curcumin and Wedelolactone
  18. Advancement of artificial intelligence based treatment strategy in type 2 diabetes: A critical update
  19. Carica papaya in health and disease: a review of its bioactive compounds for treating various disease conditions, including anti-inflammatory and anti-arthritic activities
  20. A narrative review on the use of Green synthesized metallic nanoparticles for targeted cancer therapy
  21. Flavonoids and flavonoid-based nanoparticles for the treatment of arthritis
  22. Preparation and Evaluation of N-Acetyl D-Glucosamine Ethosomal Gel for the Treatment of Hyperpigmentation
  23. A critical review on SGLT2 inhibitors for diabetes mellitus, renal health, and cardiovascular conditions
  24. The role of ACE inhibitors and ARBs in preserving cognitive function via hypertension Management: A critical Update
  25. Gut Microbiota and Postbiotic Metabolites: Biotic Intervention for Enhancing Vaccine Responses and Personalized Medicine for Disease Prevention
  26. A detailed examination of Coronavirus disease 2019 (COVID-19): covering past and future perspectives
  27. Gut microbiota modulation and health benefits of various fasting regimens
  28. Biological significance and pathophysiological role of Matrix Metalloproteinases in the Central Nervous System
  29. Mechanistic insights and therapeutic potential of astilbin and apigenin in diabetic cardiomyopathy
  30. Repurposing FDA approved drugs against Sterol C-24 methyltransferase of Leishmania donovani: A dual in silico and in vitro approach
  31. Safety Evaluation and antioxidant potential of new probiotic strain Bacillus subtilis (NMCC-path-14) in Balb/c mice by sub-acute repeated dose toxicity
  32. An Efficient Synthesis of Curcumin Pyrazole Analogues and their Biological Activities
  33. Identification of potential vaccine targets for elicitation of host immune cells against SARS-CoV-2 by reverse vaccinology approach
  34. Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in development
  35. Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?
  36. Anti-Cancer and Anti-Diabetics Potentials of Punicalagin Derivatives Extracted from Peeled of Pomegranate (Punica granatum)
  37. Nanovesicles based drug targeting to control tumor growth and metastasis
  38. Retraction Note: Role of inhibitors of serine peptidases in protecting Leishmania donovani against the hydrolytic peptidases of sand fly midgut
  39. Cadmium induced genotoxicity and antioxidative defense system in lentil (Lens culinaris Medik.) genotype
  40. High resolution cryo-EM structures of two potently SARS-CoV-2 neutralizing monoclonal antibodies of same donor origin that vary in neutralizing Omicron variants
  41. Physio-biochemical analysis and molecular characterization of induced lentil mutant lines
  42. Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy
  43. Colorectal cancer: A comprehensive review based on the novel drug delivery systems approach and its management
  44. Recent advances in novel drug delivery systems and approaches for management of breast cancer: A comprehensive review
  45. Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus
  46. Treatment and Management of Hypertension by Targeting ACE Inhibitors: in silico Approach
  47. NEXT GENERATION SEQUENCE ANALYSIS OF SEQUENCES FROM SRA FILE OF HIV-1 ENVELOPE PROTEIN.
  48. Computational elucidation of novel antagonists and binding insights by structural and functional analyses of serine hydroxymethyltransferase and interaction with inhibitors
  49. Leishmania donovani Inhibitor of Serine Peptidases 2 Mediated Inhibition of Lectin Pathway and Upregulation of C5aR Signaling Promote Parasite Survival inside Host
  50. Synthesis, Cytotoxic Evaluation, and Molecular Docking Studies of New Oxadiazole Analogues
  51. Computational elucidation, mutational and hot spot-based designing of potential inhibitors against human acid-sensing ion channels (hASIC-1a) to treat various physiological conditions
  52. Recent advancement and treatment of leishmaniasis based on pharmacoinformatics approach: Current and future outlook
  53. In silico identification of novel antagonists and binding insights by structural and functional analyses of guanylate kinase of Leishmania donovani and interaction with inhibitors
  54. Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis
  55. Role of inhibitors of serine peptidases in protecting Leishmania donovani against the hydrolytic peptidases of sand fly midgut
  56. Glucose-6-phosphate dehydrogenase and Trypanothione reductase interaction protects Leishmania donovani from metalloid mediated oxidative stress
  57. In Vitro Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate Peroxidase To Combat Amphotericin B Drug Resistance
  58. Synthesis, Biological Evaluation and Molecular Docking Studies of Pyridine Incorporated Chalcone Derivatives as Anticancer Agents
  59. Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: A first step towards vaccine development
  60. Computational Elucidation of Structural Basis for Ligand Binding with Mycobacterium tuberculosis Glucose-1-Phosphate Thymidylyltransferase (RmlA)
  61. Design and synthesis of new 2,5-disubstituted-1,3,4-oxadiazole analogues as anticancer agents
  62. In vitro studies of the antileishmanial activity of the newer 2-(substitutedphenoxy)-N-[(aryl)methylidene]acetohydrazide analogues
  63. Antileishmanial activity of sulfonamide compound
  64. Universal minicircle sequence binding protein of Leishmania donovani regulates pathogenicity by controlling expression of cytochrome-b
  65. Development of PLGA–PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis
  66. Establishment of correlation between in-silico and in-vitro test analysis against Leishmania HGPRT to inhibitors
  67. Up-regulation of cytosolic tryparedoxin in Amp B resistant isolates of Leishmania donovani and its interaction with cytosolic tryparedoxin peroxidase
  68. Current Perspectives on Novel Drug Delivery Systems and Approaches for Management of Cervical Cancer: A Comprehensive Review
  69. Computational elucidation of potential antigenic CTL epitopes in Ebola virus
  70. Synthesis, antiproliferative activity, and molecular docking studies of curcumin analogues bearing pyrazole ring
  71. Binding Pattern Elucidation of NNK and NNAL Cigarette Smoke Carcinogens with NER Pathway Enzymes: an Onco-Informatics Study
  72. Tuberculosis: Current Treatment, Diagnostics, and Newer Antitubercular Agents in Clinical Trials
  73. Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani
  74. Computational Identification of microRNA-like Elements in Leishmania major
  75. Structure, evolution and virtual screening of NDM-1 strain from Kolkata
  76. Molecular Modeling and Ligand-Protein Interaction of N-Protein of Chandipura Virus
  77. Spinigerin induces apoptotic like cell death in a caspase independent manner in Leishmania donovani
  78. Structure prediction of gBP21 protein ofL. donovaniand its molecular interaction
  79. Analysis of sequence, structure of GAPDH ofLeishmania donovaniand its interactions
  80. Computational Elucidation of Structural Basis for Ligand Binding with Leishmania donovani Adenosine Kinase
  81. Comparative modeling of HGPRT enzyme of L. donovani and binding affinities of different analogs of GMP